- Joined
- Jun 13, 2008
- Messages
- 44
- Reaction score
- 0
Do you think we're going to be seeing Labetalol in the field anytime in the near future? Does anyone's agency already do this or are they looking into it?
Do you think we're going to be seeing Labetalol in the field anytime in the near future? Does anyone's agency already do this or are they looking into it?
Labetalol is not "cardioselective."
Do you think we're going to be seeing Labetalol in the field anytime in the near future? Does anyone's agency already do this or are they looking into it?
We use labetalol for hypertensive crisis at my agency.
We used metoprolol for MI at my old agency in Virginia. I've seen ST-seg changes resolve with metoprolol.
Both work very well.
No one should be giving B-blockers in the field for MI. I'm an EM physician and I don't give them any longer for MI. New evidence in a recent New England Journal article shows increased morbidity and mortality with the use of B-blockers for acute MI. They only show benefit > 12 hours post MI because of risk of cardiogenic shock during acute MI. It will probably take some time for this practice to change, especially in the ED where we all stick with what we once learned and shy away from the new.